Skip to main content
Clinical Trials/NCT02221024
NCT02221024
Completed
Phase 3

Randomized Controlled Trial to Evaluate the Efficacy of Normal Saline Flushes at 12 and 24 Hours Intervals in Maintaining Peripheral Intravenous Catheters Patency

IRCCS Burlo Garofolo1 site in 1 country400 target enrollmentJuly 2011

Overview

Phase
Phase 3
Intervention
Normal saline
Conditions
Pain
Sponsor
IRCCS Burlo Garofolo
Enrollment
400
Locations
1
Primary Endpoint
Number of participants with peripheral intravenous catheter patency
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Children admitted in a ward often require a peripheral intravenous catheter to provide access for administration of medications, nutrients, fluids, blood products. Vascular access in children is a frequent and stressful procedure that should be performed as infrequently as possible in order to reduce the child's pain experience and the child's and family's level of distress. The maintenance of patency of indwelling catheters is therefore relevant to minimize need for replacement and children discomfort.

Recent studies investigated the most effective and safe method of maintaining peripheral intravenous lock (peripheral IVL) in children. Most of these studies focused primary on the use of heparin versus saline flushes, showing similar efficacy of the two approaches.

To the best of the investigators knowledge no study addressed the issue of the optimal flushing frequency of normal saline . The aim of this study was to evaluate the efficacy of normal saline flushes, at 12 and 24 hours intervals.

Registry
clinicaltrials.gov
Start Date
July 2011
End Date
September 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
IRCCS Burlo Garofolo
Responsible Party
Principal Investigator
Principal Investigator

Ronfani Luca

MD, PhD

IRCCS Burlo Garofolo

Eligibility Criteria

Inclusion Criteria

  • age between 1 and 17 years
  • peripheral intravenous catheter 22 G or 24 G
  • need to maintain the access for at least 24 hours without infusion

Exclusion Criteria

  • need for continuous infusion therapy
  • programmed therapy

Arms & Interventions

Flushing every 24 hours

Flushing with positive pressure with normal saline every 24 hours

Intervention: Normal saline

Flushing every 24 hours

Flushing with positive pressure with normal saline every 24 hours

Intervention: Flushing with positive pressure

Flushing every 24 hours

Flushing with positive pressure with normal saline every 24 hours

Intervention: MicroClave ICU Medica

Flushing every 12 hours

Flushing with positive pressure with normal saline every 12 hours

Intervention: Flushing with positive pressure

Flushing every 12 hours

Flushing with positive pressure with normal saline every 12 hours

Intervention: Normal saline

Flushing every 12 hours

Flushing with positive pressure with normal saline every 12 hours

Intervention: MicroClave ICU Medica

Outcomes

Primary Outcomes

Number of participants with peripheral intravenous catheter patency

Time Frame: Until catheter use (i.e. drug infusion) or removal (catether related complication or no further need of use), with an expected avarage of 48 hours

Patency was defined as the possibility of flushing the cannula with a 3 ml Becton Dickinson syringe filled with 3 ml of normal saline in less than 20 seconds without resistance at infusion, pain or erythema

Secondary Outcomes

  • Number of participants with skin redness(Until catheter use (i.e. drug infusion) or removal (catether related complication or no further need of use), with an expected avarage of 48 hours)
  • Number of participants with blood extravasation(Until catheter use (i.e. drug infusion) or removal (catether related complication or no further need of use), with an expected avarage of 48 hours)
  • Number of participants with pain(Until catheter use (i.e. drug infusion) or removal (catether related complication or no further need of use), with an expected avarage of 48 hours)
  • Number of participants with swelling(Until catheter use (i.e. drug infusion) or removal (catether related complication or no further need of use), with an expected avarage of 48 hours)

Study Sites (1)

Loading locations...

Similar Trials